WR
Washington Research Foundation
Venture CapitalActiveWashington Research Foundation supports groundbreaking technology in the life sciences, physical sciences and information sciences.
54
Investments
5
Exits
—
AUM
9.3%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Washington Research Foundation.
Investment Thesis & Strategy
Washington Research Foundation invests in groundbreaking technology across life sciences, physical sciences, and information sciences, at various stages of development.
Investment Activity
Deals per year over the last 18 years
1
20050
20061
20072
20080
20090
20100
20110
20120
20131
20140
20150
20160
20171
20180
20191
20200
20211
2022Portfolio Companies
Selected investments from their portfolio of 54 companies
V
Vilya
Biotech · Seed, 2022
U
Umoja Biopharma
Biotech · Series A, 2020
L
Lava Therapeutics
Biotech · Series A, 2018
P
PhaseRx
Biotech · Series A, 2014
P
Presage Biosciences
Biotech · Series A, 2008
I
Impel NeuroPharma
Biotech · Series A, 2008
A
Adaptive Biotechnologies
Biotech · Series A, 2007
N
NanoString Technologies
Biotech · Series A, 2005
Notable Exits
CompanyTypeYearValue / Acquirer
Adaptive BiotechnologiesIPO2019$1.4B
PhaseRxAcquisition2018—
NanoString TechnologiesIPO2013$150M
VLSTAcquisition2012—
DendreonIPO2007—
Frequently Asked Questions
Washington Research Foundation focuses on Series A, Series B, Series C+ stage investments.
Related Investors
Madrona Venture Group
Seattle, United States · 359 deals
Vulcan Capital
Seattle, United States · 194 deals
Voyager Capital
Seattle, United States · 152 deals
OVP Venture Partners
Seattle, United States · 115 deals
Second Avenue Partners
Seattle, United States · 43 deals
Frazier Technology Ventures
Seattle, United States · 39 deals